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Abstract
AIM: To evaluate clinical outcomes of patients that 
underwent surgery, transarterial embolization (TAE), or 
supportive care for spontaneously ruptured hepatocel-
lular carcinoma (HCC).
METHODS: A consecutive 54 patients who diagnosed 
as spontaneously ruptured HCC at our institution be-
tween 2003 and 2012 were retrospectively enrolled. 
HCC was diagnosed based on the diagnostic guidelines 
issued by the 2005 American Association for the Study 
of Liver Diseases. HCC rupture was defined as disrup-
tion of the peritumoral liver capsule with enhanced 
fluid collection in the perihepatic area adjacent to 
the HCC by dynamic liver computed tomography, and 
when abdominal paracentesis showed an ascitic red 
blood cell count of > 50000 mm3/mL in bloody fluid.
RESULTS: Of the 54 patients, 6 (11.1%) underwent 
surgery, 25 (46.3%) TAE, and 23 (42.6%) supportive 
care. The 2-, 4- and 6-mo cumulative survival rates at 
2, 4 and 6 mo were significantly higher in the surgery 
(60%, 60% and 60%) or TAE (36%, 20% and 20%) 
groups than in the supportive care group (8.7%, 0% 
and 0%), respectively (each, P  < 0.01), and tended to 
be higher in the surgical group than in the TAE group. 
Multivariate analysis showed that serum bilirubin (HR = 
1.09, P  < 0.01), creatinine (HR = 1.46, P  = 0.04), and 
vasopressor requirement (HR = 2.37, P  = 0.02) were 
significantly associated with post-treatment mortality, 
whereas surgery (HR = 0.41, P  < 0.01), and TAE (HR 
= 0.13, P  = 0.01) were inversely associated with post-
treatment mortality.
CONCLUSION: Post-treatment survival after surgery 
or TAE was found to be better than after supportive 
care, and surgery tended to provide better survival 
benefit than TAE.
© 2013 Baishideng. All rights reserved.
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Core tip: We have shown here that overall survival 
rates of patients with ruptured hepatocellular carcino-
ma (HCC) is significantly higher in patients with surgery 
or transarterial embolization (TAE) than in those with 
supportive care, and tended to be higher in patients 
with surgery than in those with TAE. To date, there has 
been a dearth of reliable clinical evidence on the merits 
of surgical treatment versus those of TAE, in the con-
text of survival benefit in patients with a spontaneous 
HCC rupture. Therefore, the present study may provide 
useful information for clinicians to determine the most 
appropriate treatment option for spontaneously rup-
tured HCC.
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INTRODUCTION
Hepatocellular carcinoma (HCC) is the worldwide health 
problem and the third leading cause of  cancer-related 
death globally[1-3]. Despite recent considerable advances 
in the understanding of  tumor biology and the continued 
progression and development of  diagnostic and thera-
peutic tools[4-7], the overall prognosis of  HCC remains 
disappointing. In particular, due to its hypervascularity, 
HCC can exhibit rapid progression with direct invasion 
of  surrounding tissues or it can invoke spontaneous tu-
mor rupture[8]. HCC rupture is one of  the life-threatening 
complications of  HCC, and therefore, the most efficient 
treatment modality should be selected and rapidly applied 
to patients with ruptured HCC.
 The incidence of  spontaneous HCC rupture has 
decreased due to the earlier detection of  HCC. Neverthe-
less, its incidence has been reported to be high as 3%-15% 
and its in-hospital mortality rate to range from 25% to 
75% in the acute phase[9-12]. Open surgery was the main 
method used to treat HCC rupture from the 1960s to 
the 1980s[13-15]. Recently, survival benefit by transarterial 
embolization (TAE) has been reported[16-18]. However, to 
the best of  our knowledge, no definite recommendation 
has been issued regarding optimal treatment of  HCC 
rupture, and the comparative survival benefits of  surgery 
and TAE remain unclear. 
Therefore, in this retrospective study, we undertook 
to evaluate survival outcomes according to treatment 
modalities, that is, surgery, TAE, or supportive care, in 
patients with a spontaneously ruptured HCC, and sought 
to identify the factors that predispose post-treatment 
mortality in these patients.
MATERIALS AND METHODS
Study subjects 
Between August 2003 and February 2012, 1765 consecu-
tive patients were initially diagnosed as having HCC at 
Inha University Hospital. Of  these 1765 patients, 61 
(3.5%) patients were clinically diagnosed as having spon-
taneously ruptured HCC. No patient had recent history 
of  HCC treatment such as surgery or transarterial che-
moembolization (TACE) within one month prior to the 
diagnosis of  HCC rupture. HCC was diagnosed accord-
ing to the diagnostic guidelines issued by the American 
Association for the Study of  Liver Diseases[19]. HCC 
rupture was defined as disruption of  the peritumoral liver 
capsule with enhanced fluid collection in the perihepatic 
area adjacent to the HCC by dynamic liver computed 
tomography (CT)[20], and when abdominal paracentesis 
showed an ascitic red blood cell count of  > 50000 mm3/
mL in bloody fluid[21,22]. 
Of  the 61 patients, 4 patients were excluded because 
they underwent two-staged surgical treatment after TAE 
for ruptured HCC (n = 3) and they had concurrent ma-
lignancy (gastric cancer, n = 1). Three patients were also 
excluded because they did not meet the diagnostic criteria 
of  a ruptured HCC although HCC rupture was clinically 
suspected based on right upper quadrant abdominal pain 
and a reduced serum hemoglobin level. Therefore, 54 
patients finally constituted the study cohort and their ret-
rospective database was analyzed.
Evaluation of patients with ruptured HCC 
Database information at time of  diagnosis of  ruptured 
HCC was reviewed: age, gender; vital signs; medical his-
tory; white blood cell count, hemoglobin, and platelet 
count; international normalized ratio (INR); serum alanine 
aminotransferase, bilirubin, albumin, and creatinine; viral 
hepatitis findings including hepatitis B surface antigen, 
and anti-hepatitis C virus antibody findings; serologic tests 
for human immunodeficiency virus; alpha-fetoprotein; 
and vasopressor requirement. Furthermore, we evaluated 
HCC tumor statuses namely tumor number, size, pres-
ence of  portal vein tumor thrombosis, and presence of  
extra-hepatic metastasis. Intrahepatic HCC lesion size 
was recorded as the longest diameter of  the largest lesion 
in at least one dimension. Liver cirrhosis was diagnosed 
based on clinical evidence of  portal hypertension (en-
cephalopathy, esophageal varices, ascites, splenomegaly, 
or platelet count < 100000/mm3)[23] or by previously per-
formed ultrasonography[24]. Child-Turcotte-Pugh (CTP) 
and Model for End-stage Liver Disease (MELD) scores 
were assessed, and HCC staging was performed using the 
Barcelona Clinic Liver Cancer (BCLC) staging system[25]. 
Treatment of ruptured HCCs 
Immediately following a diagnosis of  HCC rupture, pa-
tients were transferred to an intensive care unit. At time 
of  HCC rupture, liver functions can be much more ag-
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gravated by hemorrhage or shock than after the condi-
tion was relatively well controlled. Therefore, frequent 
assessments of  liver function were required concurrently 
with volume replacement and coagulopathy correction, 
and liver function was closely monitored before definite 
treatment decision making. Norepinephrine was infused 
intravenously as the primary vasopressor if  shock event 
developed, and all 54 patients were administered 3rd gen-
eration cephalosporin antimicrobial therapy. 
The need for emergency hemostasis, such as, open 
surgery or TAE, was explained to all patients in the ab-
sence of  a contraindication and their family members. 
They were informed of  the risks and benefits of  emer-
gency surgery or TAE in detail. To avoid any coercion, 
written informed consent was obtained from all patients 
and a family member before intervention of  hemosta-
sis. The follow were viewed as surgical contraindication: 
the presence of  poorly controlled chronic ascites; the 
presence of  poorly controlled chronic hepatic encepha-
lopathy; the presence of  a poor liver function; or a poor 
performance status. Of  the 54 patients enrolled, 6 (11.1%) 
underwent surgery and 25 (46.3%) TAE, and the remain-
ing 23 (42.6%) patients received supportive care without 
hemostatic intervention (Figure 1). Successful control of  
hemorrhage was defined as hemodynamic stabilization, a 
normal hemoglobin level, and no requirement for further 
transfusion. During follow-up period after treatment, dy-
namic liver CT images and serum alpha-fetoprotein levels 
were obtained every 1-3 mo. 
TAE group: In hemodynamically unstable patients with 
an obvious continuous hemorrhage, TAE was considered 
if  reserved liver function was relatively good regardless 
of  the correction of  coagulopathy. Briefly, the tumor 
location, the active bleeding site, and portal vein patency 
were determined angiographically. Thereafter, emboliza-
tion of  the feeding artery was performed with gelfoam, 
which is the small cube of  approximately 1 mm3 sized 
absorbable gelatin sponge particles. Two patients who 
underwent TACE were included in the TAE group. How-
ever, TACE/TAE was not performed if  the main portal 
vein was completely occluded by tumor thrombus.
Surgical group: After stabilizing hemodynamic status by 
volume replacement and transfusion, patients underwent 
a full clinical assessment to evaluate the possibility of  sur-
gical treatment. Segmentectomy with perihepatic packing 
(n = 3, 50%), lobectomy (n = 2, 33.3%), or liver wedge 
resection with feeding artery ligation (n = 1, 16.7%) were 
performed depending on circumstances (Figure 1).
Supportive care group: Patients contraindicated for sur-
gery or TACE/TAE received only vigorous and careful 
conservative treatments with replacement of  blood or al-
bumin, correction of  coagulopathy, antimicrobial therapy, 
and analgesics, diuretics, etc.
The study protocol was approved by the Institutional 
Review Board at Inha University Hospital, Incheon 
400-711, South Korea.
Statistical analysis
The baseline characteristics of  patients are expressed as 
medians (ranges) and frequencies. Differences between 
categorical or continuous variables were analyzed us-
ing the χ 2 test, Fisher’s exact test, or the Student’s t test. 
Post-treatment cumulative mortality rates were analyzed 
using Kaplan-Meier survival curves, and group differ-
ences were compared using the log-rank test. In patients 
that received supportive care, survival was defined from 
diagnosis of  HCC rupture to patients’ death. Multivari-
ate analysis was performed using a Cox regression hazard 
model to identify predictors of  post-treatment mortality 
in patients with spontaneously ruptured HCC. Two-tailed 
P values of  less than 0.05 were considered statistically sig-
nificant in all analyses. Statistical analysis was performed 
using SPSSv18.0 (SPSS Inc, Chicago, IL, United States).
RESULTS
Baseline characteristics of patients
The baseline characteristics of  the 54 patients are sum-
marized in Table 1. Median age was 54 years (range, 30-87 
years) and 47 (87.0%) were male. The most common 
etiology of  HCC was hepatitis B virus infection, which 
was observed in 36 (66.7%) patients. Of  the 54 patients, 
6 (11.1%) were of  CTP class A, 23 (42.6%) were of  CTP 
class B, and 5 (46.3%) were of  CTP class C. Eleven (20.4%) 
of  the 54 patients had a single HCC and 43 (79.6%) 
patients had multiple HCC. Median tumor size was 8.5 
cm (range, 2.9-25.5 cm), and 4 (7.4%) patient had HCCs 
within Milan criteria. Forty-seven (87.7%) patients had 
nodular type HCC. Before treatment, 0 (0%), 5 (9.3%), 9 
(16.7%), 15 (27.8%), and 25 (46.3%) patients were found 
to have BCLC 0, A, B, C, or D stage HCC, respectively. 
Median alpha-fetoprotein concentration at diagnosis of  
HCC rupture was 1158 ng/mL (range, 3.0 × 104-6.1 × 104 
ng/mL). Thirteen (24.1%) patients required a vasopressor 
due to shock at presentation. Ruptured HCC was located 
on the surface of  liver in all the patients.
Comparison of clinical parameters by treatment 
modality
Clinical variables in the three treatment groups are sum-
marized in Figures 2 and 3, and Table 2. Mean tumor 
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Total patients 
(n  = 54)
TAE 
n  = 25 (46.3%)
Surgery 
n  = 6 (11.1%)
Supportive care 
n  = 23 (42.6%)
Segmentectomy 
n  = 3 (50%)
Lobectomy
n = 2 (33.3%)
Wedge resection with 
ligation of feeding artery
n  = 1 (16.7%) 
Figure 1  Flow diagram showing the treatment of 54 patients. Of the 54 
patients enrolled, 6 (11.1%) underwent surgery and 25 (46.3%) transarterial 
embolization (TAE), and the remaining 23 (42.6%) patients received supportive 
care without hemostatic intervention.
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and tumor type showed no difference among three 
treatment groups. Incomplete hemostasis occurred in 1 
(16.7%) patient in the surgical group and in 5 (20%) pa-
tients in the TAE group (P = 1.00), and post-treatment 
liver failure occurred in 0 (0%) patient in the surgical 
group and in 1 (5%) patient in the TAE group (P = 0.31). 
Rebleeding after complete hemostasis was observed in 0 
(0%) patients in the surgical group and in 1 (5%) patient 
in the TAE group (P = 1.00), and they received support-
ive care (Table 2).
Cumulative overall survival of ruptured HCC patients 
according to treatment types
One-month overall cumulative mortality for the 54 study 
subjects was 63.8%. Cumulative survival rates at 2-, 4- and 
6-mo were 60.0%, 60.0% and 60.0%, respectively, in the 
surgical group and 36.0%, 20.0% and 20.0%, respectively 
in the TAE group, and 8.7%, 0% and 0%, respectively in 
the supportive care group (each, P < 0.01). Cumulative 
survival rates at 2-, 4- and 6-mo were tended to be higher 
in the surgical group than in the TAE group despite the 
statistical insignificance (P = 0.14) (Figure 4A). Cumula-
tive survival rates at 2-, 4- and 6-mo were 50.2%, 40.1% 
and 33.1%, respectively in the intervention group such as 
surgery or TAE, and 8.7%, 0% and 0%, respectively, in 
the supportive care group (P < 0.01) (Figure 4B).
Multivariate analysis for predictors of post-treatment 
mortality 
Multivariate analysis showed that surgery (HR = 0.41, P 
< 0.01), and TAE (HR = 0.13, P = 0.01) were inversely 
associated with post-treatment mortality in ruptured 
HCC patients. Serum bilirubin (HR = 1.09, P < 0.01), 
creatinine (HR = 1.46, P = 0.04), and vasopressor use (HR 
= 2.37, P = 0.02) were positively associated with post-
treatment mortality. Age, gender, INR, albumin, tumor 
size was significantly smaller in the surgical group than in 
the TAE (P = 0.02) or supportive care (P < 0.01) groups 
(Figure 2A). The single tumor rate was significantly high-
er in the surgical group than in the supportive care group 
(P < 0.01) (Figure 2B). Furthermore, the surgical group 
had better reserve hepatic function (CTP class) than the 
other two groups (both P < 0.01) (Figure 3A). Mean 
MELD score was higher in the supportive care group 
than in the other two groups (both P = 0.01), but was 
not different in the surgical and TAE groups (P = 0.24) 
(Figure 3B).
Serum platelet count (P = 0.03), total bilirubin (P < 
0.01), and creatinine levels (P < 0.01) were significantly 
lower in surgical group than supportive care group (Table 
2). The other clinical parameters including age, gender, 
P  < 0.01
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Figure 2  Comparison of clinical parameters in the three treatment groups. A: Mean tumor size was significantly smaller in the surgical group than in the transar-
terial embolization (TAE) (P = 0.02) or supportive care (P < 0.01) groups; B: The single tumor rate was significantly higher in the surgical group than in the supportive 
care group (P < 0.01).
  Variable Total (n  = 54)
  Age1, yr     54 (30-87)
  Gender (male)     47 (87.0)
  Etiology
     HBV/HCV/alcohol/others     36 (66.7)/6 (11.1)/7 (13.0)/5 (9.3)
  CTP classification
     A/B/C       6 (11.1)/23 (42.6)/25 (46.3)
  Tumor size1, cm       8.5 (2.9-25.5)
  Tumor number
     Single/multiple     11 (20.4)/43 (79.6)
  Tumor type
     Nodular/infiltrative     47 (87.0)/7 (13.0)
  Within Milan criteria       4 (7.4)
  BCLC stage
     0/A/B/C/D       0 (0.0)/3 (5.6)/8 (14.8)/15 (27.8)/28 (51.9)
  Vasopressor requirement     13 (24.0)
  Alpha-fetoprotein1, ng/mL 1158 (3.0 × 104-6.1 × 104)
Table 1  Baseline clinical characteristics of the 54 patients 
with ruptured hepatocellular carcinoma  n  (%)
1Median (range). HBV: Hepatitis B virus; HCV: Hepatitis C virus; CTP: 
Child-Turcotte-Pugh classification; BCLC: Barcelona Clinical Liver Cancer.
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size, and tumor number were not found to be associated 
with post-treatment mortality (Table 3). 
DISCUSSION
We have shown here that overall survival rates of  patients 
with ruptured HCC is significantly higher in patients with 
surgery or TAE than in those with supportive care, and 
tended to be higher in patients with surgery than in those 
with TAE. Furthermore, high serum bilirubin and creati-
nine levels, and vasopressor requirement were found to 
be significantly associated with post-treatment mortality. 
To our knowledge, this is the first study to investigate 
the survival benefit of  surgery vs TAE. Although several 
previous studies have evaluated the therapeutic efficacy 
of  surgery or TAE, in patients with spontaneous HCC 
rupture, direct comparative information is little available 
regarding survival outcomes after surgery and TAE in 
such patients. 
Spontaneous HCC rupture is likely to occur in pa-
tients with advanced staged HCC with reported incidenc-
es of  10.0% in Japan[15], 12.4% in Thailand[10], and about 
3.0% in the United Kingdom[26]. In the present study, the 
estimated incidence of  spontaneous HCC rupture was 
3.5%, and the overall 1-mo mortality was a high as 64% 
in our cohort, which are the similar to the outcomes of  
previous studies[10,11,27]. However, despite its high mortal-
ity, survival benefits for surgical treatment[13-15] and for 
TAE[16-18] have been reported in patients with a sponta-
neous HCC rupture. Likewise, in the present study, the 
  Variables Resection TAE Supportive P  value
        6 (11.1)       25 (46.3)         23 (42.6)
  Age, yr       59 (42-79)       54 (30-83)         53 (36-87) NS
  Gender (male)         5 (83.3)       22 (88.0)         20 (86.9)    0.95
  Hb1, g/dL         8.2 (5.1-12.1)         7.6 (4.5-11.2)           8.1 (2.9-13.6) NS
  Platelet1, × 103/mm3     127.5 (80-236)     139 (11-534)       191 (86-606)    0.034, NS
  Prothrombin time1, INR         1.4 (0.7-3.0)         1.3 (1.0-2.3)           2.2 (1.0-6.6) NS
  Albumin1, mg/dL         2.6 (0.4-3.5)         2.9 (1.8-3.7)           2.6 (1.2-4.3) NS
  Total bilirubin, mg/dL         2.3 (0.5-6.2)         1.2 (0.4-5.4)           6.7 (0.6-23.0) < 0.014 , NS
  Creatinine1, mg/dL         1.2 (0.8-2.0)         1.1 (0.6-1.2)           1.9 (0.9-4.9)   < 0.014, 0.015
  Tumor type
     Nodular/infiltrative         5/1 (83.3/16.7)       21/4 (84/16)         21/2 (91.3/8.7)    0.72
  BCLC stage A/B/C/D         3/2/12/0 (50.0/33.3/16.7/0)         0/4/9/12 (0/16/36/48)           0/2/5/16 (0/8.7/21.7/69.6) < 0.01
  Alpha-fetoprotein1, ng/mL       33.9 (3-3.6 × 104)   1345 (3-6.1 × 104)     1389 (19-6.1 × 104) NS
  Vasopressor requirement         1 (16.7)         7 (28.0)           5 (21.7)    0.79
  Incomplete hemostasis         1 (16.7)         5 (20) NA    1.003
  Post-treatment liver failure         0 (0)         6 (24) NA    0.313
  Rebleeding         0/5 (0)         1/20 (5.0) NA    1.003
Table 2  Clinical parameters of patients according to treatment modality  n  (%)
1Median (range); 21 patient received palliative resection; 3P value between resection and TAE group; 4P value between resection and supportive group; 5P 
value between TAE and supportive group. TAE: Transarterial embolization; BCLC: Barcelona Clinical Liver Cancer; NA: Not available; NS: Not significant. 
Figure 3  Comparison of Child-Turcotte-Pugh and Model for End-stage Liver Disease scores in the three treatment groups. A: The surgical group had better re-
serve hepatic function [Child-Turcotte-Pugh (CTP) class] than the other two groups (both P < 0.01); B: Mean Model for End-stage Liver Disease (MELD) score was higher 
in the supportive care group than in the other two groups (both P = 0.01), but was not different in the surgical and transarterial embolization (TAE) groups (P = 0.24).
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overall survivals of  patients with surgery or TAE were 
significantly higher than that in those with supportive 
care, especially in those in a hemodynamically stable state 
with a low serum bilirubin level, and good renal function. 
However, to date, there has been a dearth of  reliable 
clinical evidence on the merits of  surgical treatment ver-
sus those of  TAE, in the context of  survival benefit in 
patients with a spontaneous HCC rupture. Therefore, the 
present study may provide useful information for clini-
cians to determine the most appropriate treatment option 
for spontaneously ruptured HCC. 
Ruptured HCC is a catastrophic disorder character-
ized by fatal complications, such as, coagulopathy, hemo-
dynamic instability, or liver insufficiency. Thus, treatment 
should be considered carefully based on adequate infor-
mation. As has been found in previous studies[13-15], surgi-
cal treatment was found to provide significant survival 
benefit as compared with supportive care in the current 
study. Furthermore, surgical group had relatively better 
hepatic function reserve, smaller tumors, and smaller 
numbers of  tumors than the supportive care groups, al-
though bias might have been introduced by selection for 
surgery. Nonetheless, the cumulative overall survival rate 
was higher in surgical group than in the supportive care 
group, and surgical treatment was found to be indepen-
dent predictor of  post-treatment survival by multivariate 
analysis. Although not all patients could have undergone 
surgery due to a poor hepatic function or an unstable 
vital status, surgical hemostasis can be considered if  
hepatic dysfunction or hemodynamic instability can be 
maximally corrected immediately after initial rupture of  
a hepatoma. Furthermore, post-surgical complications 
need to be considered before treatment decision-making 
despite the absence of  an immediate severe complication 
after surgical intervention in the present study.
It has been reported that TAE is effective in achiev-
  Variables Univariate analysis Multivariate analysis1
HR 95%CI P  value HR 95%CI P  value
  Age, yr 0.99 0.96-1.01    0.18 0.98 0.95-1.01    0.14
  Gender (male) 0.88 0.37-2.09    0.77 - - -
  INR 1.77 1.30-2.41 < 0.01 0.92 0.49-1.70    0.79
  Total bilirubin, mg/dL 1.13 1.07-1.19 < 0.01 1.09 1.13-1.15 < 0.01
  Albumin, mg/dL 0.73 0.42-1.03    0.07 0.81 0.49-1.32    0.39
  Creatinine, mg/dL 1.86 1.33-2.61 < 0.01 1.46 1.01-2.13    0.04
  AFP, ng/mL 1.00 1.00-1.01    0.21 - - -
  Tumor number multiple vs single 2.45 1.09-5.54    0.03 1.14 0.46-2.83    0.78
  Tumor size, cm 1.01 0.96-1.05    0.88 - - -
  Vasopressor requirement 1.96 1.87-3.29    0.01 2.37 1.13-4.96    0.02
  Treatment type
   Supportive care (control) - - - - - -
   TACE/TAE 0.44 0.03-0.64    0.01 0.13 0.03-0.66    0.01
   Surgery 0.15 0.24-0.80 < 0.01 0.41 0.21-0.79 < 0.01
Table 3  Significant predictive factors of post-treatment mortality in spontaneously ruptured hepatocellular carcinoma patients
Subjects, n = 54; event, patient death after treatment (n = 47). 1Cox proportional hazards model. CTP: Child-Turcotte-Pugh classification; AFP: Alpha-feto-
protein; TACE: Transarterial chemoembolization; TAE: Transarterial embolization; INR: International normalized ratio.
Figure 4  Cumulative overall survival according to treatment types. A: Cumulative survival rates at 2-, 4- and 6-mo in the surgical group or in the transarterial em-
bolization (TAE) group were significantly higher in the supportive care group (each, P < 0.01); B: Cumulative survival rates at 2-, 4- and 6-mo were significantly higher 
in the intervention group such as surgery and TAE than in the supportive care group (P < 0.01). 
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ing immediate hemostasis for ruptured HCC. In the 
present study, the overall survival rate was better in the 
TAE group than in the supportive care group. Advanced 
angiographic techniques enable the tumor location, active 
bleeding focus, and portal vein patency to be assessed, but 
life-threatening complications, such as, liver failure can de-
veloped after TAE, at rates ranging from 12% to 34%[12,17]. 
In the present study, post-TAE liver failure and technical 
failure for immediate hemostasis was observed in 6 (24%) 
and 5 (20%) patients of  the TAE group, respectively, 
which suggests that TAE should be selectively admin-
istered in patients with good reserved hepatic function, 
tolerable coagulopathy, and a patent main portal vein.
In terms of  comparison of  survival benefits between 
the surgical and TAE groups, the current study failed to 
show a significant difference, although the cumulative 
overall survival rate tended to be higher in the surgical 
treatment group. Although TAE is less invasive than 
open surgical hemostasis, we suppose that open surgical 
treatment offer a higher chance of  successfully achiev-
ing hemostasis by removing the bleeding focus or by 
allowing complete ligation of  feeding artery. In previ-
ous studies, the 30-d mortality rate after TAE group has 
been reported to be lower than that after open surgical 
group[12,17,28]. However, in the present study, cumula-
tive overall 1-mo survival rates were statistically similar 
between two groups. Moreover, at 1 mo after operative 
treatment, cumulative survival was clinically higher in the 
surgical group than in the TAE group despite the statisti-
cal insignificance (Figure 4). However, it should be borne 
in mind that this lack of  significance may have been due 
to small patient numbers. Therefore, large number of  
patients who underwent surgical treatment need to be 
evaluated in the comparative study in the future.
Patients with a poor liver function reserve cannot 
tolerate surgical resection or aggressive angiographic in-
tervention. Therefore, CTP class or MELD score, which 
reflect reserved hepatic function, could be important 
pretreatment factors. However, in the present study, of  
variables comprising the CTP class, only serum bilirubin 
was found to be independently associated with post-
treatment survival. Likewise, of  the variables comprising 
the MELD scores, only serum bilirubin and creatinine 
were found to be independent factors. Therefore, we esti-
mated individual variables of  CTP class or MELD score 
to avoid overestimation of  the other factors in the multi-
variate analysis of  post-treatment survival in patients with 
spontaneous HCC rupture.
Elevated serum creatinine and vasopressor require-
ments are likely to reflect multiorgan failure[29], and de-
creased effective circulating volume or the presence of  
superimposed infection may induce alterations in organ 
perfusion and in hemodynamic stability. Moreover, in-
flammatory reactions triggered by hepatocellular necrosis 
after HCC rupture may contribute to liver insufficiency, 
and subsequent multiorgan failure. Although decreased 
serum albumin level and a prolonged prothrombin time 
suggest reduced liver synthetic function, they can be 
corrected by albumin and coagulation factor replace-
ment. On the other hand, serum bilirubin level cannot 
be rapidly and artificially corrected immediately after 
parenchymal liver damage. Therefore, serum bilirubin 
may be an independent factor of  patient survival, unlike 
serum albumin or INR. Furthermore, the importance of  
serum bilirubin level in patients with HCC rupture has 
been previously reported[17,30]. However, during treatment 
decision-making, age, INR, albumin, and tumor size and 
number may also be clinically important variables despite 
their lack of  statistical significance in the present study.
Our study has several limitations. First, the study is 
inherently limited by its retrospective study design. How-
ever, we enrolled all eligible patients. Second, the varied 
clinical and tumor statuses of  patients and the critical dis-
ease status prevented randomization, and probably intro-
duced bias. Furthermore, it takes long time to collect the 
prospective database of  patients due to low incidence of  
the disease. Third, the absolute number of  patients who 
underwent surgery was small, and therefore, there might 
be no significant difference in cumulative survival rate be-
tween surgery and TAE groups. Accordingly, we suggest a 
large-scale study be conducted to confirm our study.
In conclusions, the present study suggests that the 
post-treatment outcomes of  surgery or TAE are better 
than that of  supportive care in patients with spontaneous 
HCC rupture, and that surgical hemostasis might provide 
better survival benefit than TAE. However, we advise 
that serum bilirubin, creatinine, and hemodynamic status 
should be considered during treatment decision mak-
ing. Regardless of  its shortcomings, we believe that the 
present study would provide important information that 
aids decision making in patients with spontaneous HCC 
rupture.
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